Blog Section

Study Finds Connection Between Proximity To Tobacco Retailer, Chances Of Quitting Smoking

Study Finds Connection Between Proximity To Tobacco Retailer, Chances Of Quitting Smoking

A Finnish study published online in JAMA Internal Medicine found that “found that every 500-meter (about one third of a mile) increase in distance to the nearest tobacco shop increased an individual’s odds of quitting by 20 percent to 60 percent.”

More

Smokers are more likely to try quitting and succeed with graphic warnings on cigarette packs

Smokers are more likely to try quitting and succeed with graphic warnings on cigarette packs

Smokers are more likely to try quitting and succeed with graphic warnings on cigarette packs

Smokers are more likely to try quitting and more successful at quitting if they are given cigarette packs with graphic warnings compared to smokers given cigarette packs with only text warnings, according to a new study published in JAMA Internal Medicine.

More

Immunotherapy Tablets For Dust Mite Allergy Reduce Asthma Risk

Immunotherapy Tablets For Dust Mite Allergy Reduce Asthma Risk

Immunotherapy Tablets For Dust Mite Allergy Reduce Asthma Risk

Are allergy shots going out of favor.  This is good news for patients and bad news for allergist who make most of their income out of allergy shots for at least 3 years.  The tablets are much more convenient however the price might be very high!

In 2014, the Food and Drug Administration approved Oralair for grass allergies. It was the first sublingual allergy immunotherapy tablet approved for use in the United States. It then approved Grastek, also for grass allergies, and Ragwitek, for ragweed allergies.

More

USPSTF: COPD screening in asymptomatic adults offers no benefit

USPSTF: COPD screening in asymptomatic adults offers no benefit

Similar to 2008, the USPSTF did not find evidence that screening for COPD in asymptomatic persons improves health-related quality of life, morbidity, or mortality. The USPSTF determined that early detection of COPD, before the development of symptoms, does not alter the course of the disease or improve patient outcomes. The USPSTF concludes with moderate certainty that screening for COPD in asymptomatic persons has no net benefit.

More

Antacids Don’t Improve Pulmonary Fibrosis Outcome

Antacids Don’t Improve Pulmonary Fibrosis Outcome

The debate continues!!!

In the newly published analysis, which included pooled data from the placebo groups of three pirfenidone studies, researchers analyzed the effects of antacid treatment use from baseline on pulmonary function, exercise tolerance, survival, hospital admission, and adverse events over the course of a year.

More